InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the complete record of transactions filed by O'Brien Anthony Stephen, Director. Director active across 2 companies, notably Evofem Biosciences, Inc.. Cumulatively, 1 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 14 June 2021. The latest transaction was filed on 14 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to O'Brien Anthony Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
8,140 shares@ US$1.31100.0% of flowCommon StockSEC:0001618835-21-000153:0
Canonical exit: 12 Sept 2021 (T+90)
1 of 1 declaration
About O'Brien Anthony Stephen
Anthony Stephen O'Brien is a Board Member at Evofem Biosciences, Inc. He plays an important role in the governance of the company, bringing his expertise in the life sciences field. As a board member, Anthony Stephen O'Brien contributes to the formulation of strategies that promote innovation and growth. His industry experience enables him to guide the company through regulatory and commercial challenges.
